Given lingering exclusivity around once-weekly semaglutide and tirzepatide until at least 2031, the GLP-1 agonists industry will likely remain a duopoly in premium markets, with incremental erosion from value-tier competition rather than disruptive share shifts
There is no evidence that maintaining an ACR threshold of 2 mg/mmol will cause either harm or increase costs, from the slight expansion of the number of people diagnosed with abnormal albuminuria
Infused with glutathione, alpha arbutin, and plant essences, this formula works to inhibit melanin production, exfoliate dead skin cells, and provide a radiant, luminous glow
doi: 10.1016/j.jiph.2023.01.012 150 YangHPanYChenWYangXLiuBYuanNet al
Regular supplementation helps patients with osteoarthritis reduce inflammation and improve joint function